Vivakor Highlights Benefits of VivaBlend in Preventing Chronic Disease


CORALVILLE, Iowa, May 4, 2010 (GLOBE NEWSWIRE) -- Vivakor, Inc.'s (OTCBB:VIVK) management highlights VivaBlend as a bioactive nutraceutical supplement. Plant-based foods contain significant amounts of bioactive phytochemicals which provide desirable health benefits beyond basic nutrition to reduce the risk of chronic diseases such as heart disease, Alzheimer's, osteoporosis, arthritis and cancer . Phytochemicals (or plant chemicals) are bioactive non-nutrient plant compounds in fruits, vegetables, grains and legumes.  Research into the mode, bioavailability and function of these phytochemicals is an area of intense investigation by leading scientists and clinicians.  Many phytochemicals have been linked to a reduction in the risk of major chronic diseases and aging.  Vivakor has developed a proprietary blend of fruits, vegetables, legumes and other edible plants as the powerful balance of phytochemicals. 

The powerful ingredients of VivaBlend have been shown through independent scientific investigation to be rich in critical phytochemicals and antioxidants.  Dr. Tannin Fuja, CEO & Chief Scientist stated, "The broad spectrum of health benefits of the component ingredients of VivaBlend results from the carefully selected diversity in phytochemical-rich fruits, vegetables, legumes and spices blended together in VivaBlend.  As demand continues to explode for scientifically sound products, rich phytochemicals and bioactive ingredients, we are pleased to offer VivaBlend as a premier source of balanced phytochemicals to this multi-billion dollar nutraceutical and supplement market."   

About Vivakor, Inc.

Vivakor™ is a biomedical/biotechnology company with transdisciplinary research that develops and acquires products in the fields of molecular medicine, electro-optics, biological handling and natural and formulary compounds that extend or improve life. More information can be found about Vivakor at www.vivakor.com.

FORWARD-LOOKING STATEMENTS

This press release may contain forward-looking statements, including, but not limited to, statements regarding Vivakor's products and their related market potential. Forward-looking statements may be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, risks and uncertainties discussed in Vivakor's filings with the Securities and Exchange Commission, which factors are incorporated herein by reference. Readers are cautioned not to place undue reliance on any of these forward-looking statements. Vivakor undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this press release or to reflect actual outcomes.



            

Coordonnées